Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för John A III Herrmann. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att John A III Herrmann har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:NVAX / Novavax, Inc. | EVP, Chief Legal Officer | 13 233 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av John A III Herrmann. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp NVAX / Novavax, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i NVAX / Novavax, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i NVAX / Novavax, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av John A III Herrmann som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-12-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −700 | 13 233 | −5,02 | 5,69 | −3 983 | 75 296 | |
2023-12-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 2 100 | 13 933 | 17,75 | ||||
2023-06-27 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −278 | 11 833 | −2,30 | 6,70 | −1 863 | 79 281 | |
2023-06-27 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 833 | 12 111 | 7,39 | ||||
2023-03-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −1 780 | 11 278 | −13,63 | 6,52 | −11 606 | 73 533 | |
2023-03-14 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 4 609 | 13 058 | 54,55 | 6,52 | 30 051 | 85 138 | |
2022-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −700 | 8 449 | −7,65 | 17,23 | −12 061 | 145 576 | |
2022-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 2 100 | 9 149 | 29,79 | ||||
2022-09-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −258 | 3 384 | −7,08 | 18,87 | −4 868 | 63 856 | |
2022-09-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 667 | 3 642 | 22,42 | ||||
2022-09-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −1 324 | 7 049 | −15,81 | 18,87 | −24 984 | 133 015 | |
2022-09-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 3 973 | 8 373 | 90,30 | ||||
2022-08-26 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −772 | 2 975 | −20,60 | 37,07 | −28 618 | 110 283 | |
2022-08-26 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 2 000 | 3 747 | 114,48 | ||||
2022-06-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −278 | 4 400 | −5,94 | 51,67 | −14 364 | 227 348 | |
2022-06-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 833 | 4 678 | 21,66 | ||||
2022-03-14 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 13 825 | 13 825 | |||||
2022-03-14 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 20 737 | 20 737 | |||||
2022-01-05 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 80 000 | −5,88 | |||
2022-01-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 3 845 | −2,53 | 144,43 | −14 443 | 555 333 |
2022-01-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 003 | 3 945 | −20,27 | 143,64 | −144 070 | 566 656 |
2022-01-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −800 | 4 948 | −13,92 | 142,65 | −114 117 | 705 814 |
2022-01-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −800 | 5 748 | −12,22 | 141,69 | −113 350 | 814 420 |
2022-01-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −500 | 6 548 | −7,09 | 140,05 | −70 026 | 917 060 |
2022-01-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −997 | 7 048 | −12,39 | 139,08 | −138 660 | 980 213 |
2022-01-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 8 045 | −4,74 | 137,85 | −55 140 | 1 109 003 |
2022-01-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 8 445 | −4,52 | 136,82 | −54 728 | 1 155 445 |
2022-01-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 5 000 | 8 845 | 130,04 | 19,08 | 95 400 | 168 763 |
2021-12-22 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 85 000 | −5,56 | |||
2021-12-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −5 000 | 3 845 | −56,53 | 230,00 | −1 150 000 | 884 350 |
2021-12-22 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 5 000 | 8 845 | 130,04 | 19,08 | 95 400 | 168 763 |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −2 100 | 4 200 | −33,33 | ||||
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −1 015 | 3 845 | −20,88 | 168,43 | −170 956 | 647 613 | |
2021-12-16 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 2 100 | 4 860 | 76,09 | ||||
2021-12-03 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 90 000 | −5,26 | |||
2021-12-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −366 | 2 760 | −11,71 | 202,36 | −74 064 | 558 518 |
2021-12-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 3 126 | −8,76 | 200,92 | −60 276 | 628 076 |
2021-12-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 3 426 | −8,05 | 199,81 | −59 944 | 684 560 |
2021-12-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 3 726 | −9,69 | 198,35 | −79 340 | 739 052 |
2021-12-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 4 126 | −6,78 | 197,19 | −59 156 | 813 592 |
2021-12-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −943 | 4 426 | −17,56 | 196,11 | −184 932 | 867 983 |
2021-12-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −900 | 5 369 | −14,36 | 194,54 | −175 085 | 1 044 479 |
2021-12-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −800 | 6 269 | −11,32 | 193,79 | −155 034 | 1 214 885 |
2021-12-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −691 | 7 069 | −8,90 | 192,64 | −133 113 | 1 361 757 |
2021-12-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 5 000 | 7 760 | 181,16 | 19,08 | 95 400 | 148 061 |
2021-12-01 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 95 000 | −5,00 | |||
2021-12-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −5 000 | 2 760 | −64,43 | 228,72 | −1 143 600 | 631 267 |
2021-12-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 5 000 | 7 760 | 181,16 | 19,08 | 95 400 | 148 061 |
2021-11-05 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 100 000 | −4,76 | |||
2021-11-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −5 000 | 2 760 | −64,43 | 200,00 | −1 000 000 | 552 000 |
2021-11-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 5 000 | 7 760 | 181,16 | 19,08 | 95 400 | 148 061 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 105 000 | −4,55 | |||
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −157 | 2 760 | −5,38 | 173,15 | −27 185 | 477 894 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 2 917 | −9,33 | 172,44 | −51 733 | 503 017 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −500 | 3 217 | −13,45 | 170,88 | −85 441 | 549 727 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 3 717 | −5,11 | 169,04 | −33 809 | 628 340 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 3 917 | −9,27 | 168,32 | −67 328 | 659 309 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 4 317 | −4,43 | 167,14 | −33 429 | 721 565 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 4 517 | −4,24 | 165,66 | −33 133 | 748 309 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 4 717 | −5,98 | 164,02 | −49 205 | 773 667 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 5 017 | −1,95 | 162,69 | −16 269 | 816 216 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 5 117 | −7,25 | 162,10 | −64 840 | 829 466 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −343 | 5 517 | −5,85 | 159,90 | −54 847 | 882 190 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 5 860 | −6,39 | 158,54 | −63 414 | 929 015 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −800 | 6 260 | −11,33 | 157,42 | −125 936 | 985 449 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 7 060 | −4,08 | 155,96 | −46 788 | 1 101 078 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 7 360 | −5,15 | 155,16 | −62 065 | 1 141 996 |
2021-11-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 5 000 | 7 760 | 181,16 | 19,08 | 95 400 | 148 061 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 110 000 | −4,35 | |||
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −48 | 2 760 | −1,71 | 190,63 | −9 150 | 526 139 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 2 808 | −9,65 | 189,68 | −56 905 | 532 631 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 3 108 | −3,12 | 181,36 | −18 136 | 563 667 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −352 | 3 208 | −9,89 | 179,27 | −63 103 | 575 097 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −600 | 3 560 | −14,42 | 178,00 | −106 798 | 633 668 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −500 | 4 160 | −10,73 | 177,02 | −88 509 | 736 395 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −500 | 4 660 | −9,69 | 175,91 | −87 953 | 819 722 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 5 160 | −7,19 | 174,74 | −69 895 | 901 646 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 5 560 | −6,71 | 173,82 | −69 530 | 966 467 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 5 960 | −3,25 | 172,46 | −34 492 | 1 027 862 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −600 | 6 160 | −8,88 | 171,60 | −102 960 | 1 057 056 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 6 760 | −2,87 | 169,17 | −33 834 | 1 143 589 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 6 960 | −4,13 | 168,03 | −50 410 | 1 169 512 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 7 260 | −1,36 | 166,19 | −16 619 | 1 206 539 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 7 360 | −5,15 | 165,40 | −66 158 | 1 217 307 |
2021-10-05 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 5 000 | 7 760 | 181,16 | 19,08 | 95 400 | 148 061 |
2021-09-28 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −666 | 667 | −49,96 | ||||
2021-09-28 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −3 973 | 3 973 | −50,00 | ||||
2021-09-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −222 | 1 747 | −11,27 | 248,16 | −55 092 | 433 536 | |
2021-09-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 666 | 1 969 | 51,11 | ||||
2021-09-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −1 919 | 2 760 | −41,01 | 248,16 | −476 219 | 684 922 | |
2021-09-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 3 973 | 4 679 | 562,75 | ||||
2021-09-24 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −2 000 | 2 000 | −50,00 | ||||
2021-09-24 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −697 | 1 303 | −34,85 | 233,01 | −162 408 | 303 612 | |
2021-09-24 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 2 000 | 2 000 | |||||
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 115 000 | −4,17 | |||
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −262 | 706 | −27,07 | 234,90 | −61 543 | 165 838 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 968 | −23,66 | 232,57 | −69 771 | 225 128 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 112 | 1 268 | −46,72 | 231,91 | −257 882 | 294 060 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −500 | 2 380 | −17,36 | 230,52 | −115 260 | 548 638 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −800 | 2 880 | −21,74 | 229,57 | −183 655 | 661 158 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 3 680 | −7,54 | 228,22 | −68 466 | 839 850 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −520 | 3 980 | −11,56 | 227,34 | −118 217 | 904 816 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −906 | 4 500 | −16,76 | 226,34 | −205 061 | 1 018 514 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −200 | 5 406 | −3,57 | 224,94 | −44 987 | 1 215 999 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 5 606 | −1,75 | 223,51 | −22 351 | 1 252 997 |
2021-09-17 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 5 000 | 5 706 | 708,22 | 19,08 | 95 400 | 108 870 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −5 000 | 120 000 | −4,00 | |||
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 706 | −12,41 | 237,23 | −23 723 | 167 484 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −600 | 806 | −42,67 | 256,01 | −153 606 | 206 344 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 1 406 | −22,15 | 254,83 | −101 932 | 358 291 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −600 | 1 806 | −24,94 | 253,20 | −151 919 | 457 276 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 2 406 | −14,26 | 251,68 | −100 673 | 605 548 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −344 | 2 806 | −10,92 | 250,00 | −86 000 | 701 502 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 3 150 | −3,08 | 248,33 | −24 833 | 782 240 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 3 250 | −8,45 | 246,80 | −74 041 | 802 111 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −500 | 3 550 | −12,35 | 245,82 | −122 911 | 872 668 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −400 | 4 050 | −8,99 | 244,33 | −97 731 | 989 526 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −500 | 4 450 | −10,10 | 242,97 | −121 487 | 1 081 234 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 4 950 | −1,98 | 241,39 | −24 139 | 1 194 880 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −300 | 5 050 | −5,61 | 240,51 | −72 153 | 1 214 576 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −256 | 5 350 | −4,57 | 238,81 | −61 134 | 1 277 610 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −100 | 5 606 | −1,75 | 235,85 | −23 585 | 1 322 175 |
2021-09-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 5 000 | 5 706 | 708,22 | 19,08 | 95 400 | 108 870 |
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 062 | 53 626 | −3,70 | |||
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −417 | 7 092 | −5,55 | |||
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −417 | 7 092 | −5,55 | |||
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −68 | 706 | −8,79 | 204,57 | −13 911 | 144 424 |
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −58 | 774 | −6,97 | 203,45 | −11 800 | 157 474 |
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −129 | 832 | −13,42 | 202,58 | −26 132 | 168 544 |
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −209 | 961 | −17,86 | 201,56 | −42 126 | 193 701 |
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −256 | 1 170 | −17,95 | 200,47 | −51 321 | 234 555 |
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −224 | 1 426 | −13,58 | 199,47 | −44 680 | 284 439 |
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −317 | 1 650 | −16,12 | 198,20 | −62 830 | 327 035 |
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −485 | 1 967 | −19,78 | 197,47 | −95 773 | 388 423 |
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −313 | 2 452 | −11,32 | 196,12 | −61 386 | 480 887 |
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −263 | 2 765 | −8,69 | 195,29 | −51 361 | 539 974 |
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −423 | 3 028 | −12,26 | 194,26 | −82 171 | 588 214 |
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −151 | 3 451 | −4,19 | 193,09 | −29 156 | 666 338 |
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 062 | 3 602 | 133,90 | 5,95 | 12 269 | 21 432 |
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 417 | 1 540 | 37,13 | 46,00 | 19 182 | 70 840 |
2021-07-28 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 417 | 1 123 | 59,07 | 27,60 | 11 509 | 30 995 |
2021-07-02 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | 2 063 | 55 688 | 3,85 | |||
2021-07-02 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | 417 | 7 509 | 5,88 | |||
2021-07-02 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | 416 | 2 512 | 19,85 | |||
2021-07-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −11 | 706 | −1,53 | 216,85 | −2 385 | 153 096 |
2021-07-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −192 | 717 | −21,12 | 216,11 | −41 493 | 154 952 |
2021-07-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −299 | 909 | −24,75 | 215,16 | −64 333 | 195 582 |
2021-07-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −360 | 1 208 | −22,96 | 214,23 | −77 122 | 258 788 |
2021-07-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −313 | 1 568 | −16,64 | 212,98 | −66 664 | 333 960 |
2021-07-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 126 | 1 881 | −37,45 | 212,14 | −238 866 | 399 030 |
2021-07-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −171 | 3 007 | −5,38 | 211,22 | −36 119 | 635 142 |
2021-07-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −309 | 3 178 | −8,86 | 209,89 | −64 857 | 667 046 |
2021-07-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −115 | 3 487 | −3,19 | 208,75 | −24 007 | 727 922 |
2021-07-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 063 | 3 602 | 134,05 | 5,95 | 12 275 | 21 432 |
2021-07-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 417 | 1 539 | 37,17 | 46,00 | 19 182 | 70 794 |
2021-07-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 416 | 1 122 | 58,92 | 27,60 | 11 482 | 30 967 |
2021-06-29 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −834 | 1 666 | −33,36 | ||||
2021-06-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −403 | 706 | −36,34 | 189,79 | −76 485 | 133 992 | |
2021-06-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 834 | 1 109 | 303,27 | ||||
2021-06-02 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | 2 062 | 57 751 | 3,70 | |||
2021-06-02 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | 417 | 7 926 | 5,55 | |||
2021-06-02 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | 416 | 2 928 | 16,56 | |||
2021-06-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −70 | 275 | −20,29 | 153,49 | −10 744 | 42 210 |
2021-06-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −95 | 345 | −21,59 | 152,11 | −14 450 | 52 478 |
2021-06-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −240 | 440 | −35,29 | 151,08 | −36 258 | 66 473 |
2021-06-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −517 | 680 | −43,19 | 149,81 | −77 452 | 101 871 |
2021-06-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 109 | 1 197 | −48,09 | 148,88 | −165 105 | 178 206 |
2021-06-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −864 | 2 306 | −27,26 | 147,85 | −127 739 | 340 932 |
2021-06-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 062 | 3 170 | 186,10 | 5,95 | 12 269 | 18 862 |
2021-06-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 417 | 1 108 | 60,35 | 46,00 | 19 182 | 50 968 |
2021-06-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 416 | 691 | 151,27 | 27,60 | 11 482 | 19 072 |
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | 2 063 | 59 813 | 3,57 | |||
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | 416 | 8 343 | 5,25 | |||
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | 416 | 8 343 | 5,25 | |||
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −20 | 275 | −6,78 | 248,26 | −4 965 | 68 272 |
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −128 | 295 | −30,26 | 247,32 | −31 657 | 72 960 |
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −192 | 423 | −31,22 | 246,17 | −47 264 | 104 128 |
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −31 | 615 | −4,80 | 245,02 | −7 596 | 150 690 |
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −59 | 646 | −8,37 | 243,75 | −14 381 | 157 460 |
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −145 | 705 | −17,06 | 243,05 | −35 242 | 171 348 |
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −359 | 850 | −29,69 | 241,81 | −86 809 | 205 538 |
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −207 | 1 209 | −14,62 | 240,06 | −49 693 | 290 236 |
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −447 | 1 416 | −23,99 | 239,31 | −106 973 | 338 869 |
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −267 | 1 863 | −12,54 | 238,05 | −63 559 | 443 487 |
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −576 | 2 130 | −21,29 | 237,06 | −136 548 | 504 945 |
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −464 | 2 706 | −14,64 | 236,27 | −109 629 | 639 344 |
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 063 | 3 170 | 186,36 | 5,95 | 12 275 | 18 862 |
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 416 | 1 107 | 60,20 | 46,00 | 19 136 | 50 922 |
2021-05-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 416 | 691 | 151,27 | 27,60 | 11 482 | 19 072 |
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 062 | 61 876 | −3,22 | |||
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −416 | 8 759 | −4,53 | |||
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −416 | 8 759 | −4,53 | |||
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −47 | 275 | −14,60 | 196,12 | −9 218 | 53 933 |
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −56 | 322 | −14,81 | 194,74 | −10 905 | 62 706 |
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −151 | 378 | −28,54 | 192,82 | −29 116 | 72 887 |
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −245 | 529 | −31,65 | 191,38 | −46 888 | 101 239 |
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −252 | 774 | −24,56 | 190,10 | −47 905 | 147 136 |
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −164 | 1 026 | −13,78 | 189,06 | −31 007 | 193 981 |
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −164 | 1 190 | −12,11 | 187,08 | −30 681 | 222 627 |
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 075 | 1 354 | −44,26 | 185,73 | −199 665 | 251 485 |
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −145 | 2 429 | −5,63 | 184,59 | −26 766 | 448 380 |
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −256 | 2 574 | −9,05 | 183,35 | −46 937 | 471 935 |
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −171 | 2 830 | −5,70 | 181,86 | −31 099 | 514 673 |
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −168 | 3 001 | −5,30 | 181,09 | −30 423 | 543 445 |
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 062 | 3 169 | 186,27 | 5,95 | 12 269 | 18 856 |
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 416 | 1 107 | 60,20 | 46,00 | 19 136 | 50 922 |
2021-03-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 416 | 691 | 151,27 | 27,60 | 11 482 | 19 072 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 063 | 63 938 | −3,13 | |||
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −416 | 9 175 | −4,34 | |||
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −416 | 9 175 | −4,34 | |||
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −12 | 275 | −4,18 | 232,35 | −2 788 | 63 896 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −59 | 287 | −17,05 | 231,40 | −13 653 | 66 413 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −38 | 346 | −9,90 | 230,04 | −8 742 | 79 595 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −369 | 384 | −49,00 | 228,64 | −84 368 | 87 797 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −569 | 753 | −43,04 | 227,82 | −129 628 | 171 547 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −538 | 1 322 | −28,92 | 226,59 | −121 905 | 299 550 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −248 | 1 860 | −11,76 | 225,45 | −55 913 | 419 345 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −120 | 2 108 | −5,39 | 224,93 | −26 991 | 474 145 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −188 | 2 228 | −7,78 | 223,48 | −42 014 | 497 909 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −227 | 2 416 | −8,59 | 222,39 | −50 483 | 537 295 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −250 | 2 643 | −8,64 | 221,32 | −55 330 | 584 945 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −168 | 2 893 | −5,49 | 220,33 | −37 016 | 637 422 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −109 | 3 061 | −3,44 | 219,55 | −23 930 | 672 029 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 063 | 3 170 | 186,36 | 5,95 | 12 275 | 18 862 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 416 | 1 107 | 60,20 | 46,00 | 19 136 | 50 922 |
2021-03-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 416 | 691 | 151,27 | 27,60 | 11 482 | 19 072 |
2021-02-03 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −8 249 | 66 001 | −11,11 | |||
2021-02-03 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 080 | 9 591 | −17,82 | |||
2021-02-03 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 085 | 4 592 | −31,23 | |||
2021-02-03 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 214 | 0 | −100,00 | |||
2021-02-03 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −394 | 0 | −100,00 | |||
2021-02-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −3 754 | 275 | −93,17 | 243,25 | −913 160 | 66 894 |
2021-02-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −2 200 | 4 029 | −35,32 | 242,20 | −532 833 | 975 811 |
2021-02-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −3 331 | 6 229 | −34,84 | 241,51 | −804 459 | 1 504 345 |
2021-02-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −4 294 | 9 560 | −30,99 | 240,43 | −1 032 399 | 2 298 494 |
2021-02-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 443 | 13 854 | −9,43 | 239,04 | −344 938 | 3 311 689 |
2021-02-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 8 249 | 15 297 | 117,04 | 5,95 | 49 082 | 91 017 |
2021-02-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 080 | 7 048 | 41,87 | 46,00 | 95 680 | 324 208 |
2021-02-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 085 | 4 968 | 72,32 | 27,60 | 57 546 | 137 117 |
2021-02-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 2 214 | 2 883 | 330,94 | 27,00 | 59 778 | 77 841 |
2021-02-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 394 | 669 | 143,27 | 27,00 | 10 638 | 18 063 |
2020-12-16 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 6 300 | 6 300 | |||||
2020-12-16 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 12 700 | 12 700 | |||||
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −1 574 | 275 | −85,13 | 109,28 | −172 001 | 30 051 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −3 419 | 1 849 | −64,90 | 108,39 | −370 586 | 200 414 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −7 061 | 5 268 | −57,27 | 107,30 | −757 643 | 565 255 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −5 975 | 1 239 | −82,83 | 106,18 | −634 437 | 131 559 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | X | −24 750 | 74 250 | −25,00 | |||
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −546 | 18 304 | −2,90 | 117,07 | −63 901 | 2 142 769 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −941 | 18 850 | −4,76 | 116,08 | −109 242 | 2 188 051 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −992 | 19 791 | −4,78 | 115,23 | −114 365 | 2 280 549 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −397 | 20 783 | −1,87 | 113,81 | −45 183 | 2 365 382 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −720 | 21 180 | −3,29 | 113,02 | −81 326 | 2 393 848 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −213 | 21 900 | −0,96 | 111,92 | −23 882 | 2 451 127 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −2 320 | 22 113 | −9,49 | 110,97 | −257 424 | 2 453 964 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −8 052 | 24 433 | −24,79 | 109,98 | −885 495 | 2 687 114 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −6 595 | 32 485 | −16,88 | 109,07 | −719 281 | 3 543 077 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −3 702 | 39 079 | −8,65 | 108,20 | −400 515 | 4 228 238 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | X | −273 | 42 781 | −0,63 | 107,22 | −29 264 | 4 587 009 |
2020-09-30 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | X | 24 750 | 43 054 | 135,22 | 5,95 | 147 262 | 256 171 |
2020-09-29 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −3 973 | 7 946 | −33,33 | ||||
2020-09-29 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −30 900 | 0 | −100,00 | ||||
2020-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −1 919 | 18 304 | −9,49 | 113,56 | −217 922 | 2 078 602 | |
2020-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 3 973 | 20 223 | 24,45 | ||||
2020-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −14 925 | 16 250 | −47,87 | 113,56 | −1 694 883 | 1 845 350 | |
2020-09-29 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 30 900 | 31 175 | 11 236,36 | ||||
2020-08-26 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 125 000 | 125 000 | |||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −8 328 | 11 671 | −41,64 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −13 322 | 6 677 | −66,61 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −1 952 | 4 298 | −31,23 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −393 | 394 | −49,94 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −11 249 | 0 | −100,00 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −2 499 | 0 | −100,00 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −7 499 | 0 | −100,00 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
M - Exercise | −1 000 | 0 | −100,00 | ||||
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −21 648 | 275 | −98,75 | 144,79 | −3 134 414 | 39 817 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −24 594 | 21 923 | −52,87 | 143,92 | −3 539 568 | 3 155 158 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 8 328 | 46 517 | 21,81 | 46,00 | 383 088 | 2 139 782 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 13 322 | 38 189 | 53,57 | 27,60 | 367 687 | 1 054 016 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 1 952 | 24 867 | 8,52 | 27,00 | 52 704 | 671 409 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 393 | 22 915 | 1,74 | 27,00 | 10 611 | 618 705 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 11 249 | 22 522 | 99,79 | 99,80 | 1 122 650 | 2 247 696 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 2 499 | 11 273 | 28,48 | 91,00 | 227 409 | 1 025 843 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 7 499 | 8 774 | 588,16 | 36,60 | 274 463 | 321 128 | |
2020-08-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 1 000 | 1 275 | 363,64 | 50,00 | 50 000 | 63 750 | |
2020-06-29 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 2 500 | 2 500 | |||||
2020-05-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to buy) |
M - Exercise | −5 462 | 787 | −87,41 | ||||
2020-05-20 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to buy) |
M - Exercise | −7 499 | 0 | −100,00 | ||||
2020-05-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −5 462 | 275 | −95,21 | 49,44 | −270 041 | 13 596 | |
2020-05-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 5 462 | 5 737 | 1 986,18 | 27,00 | 147 474 | 154 899 | |
2020-05-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −7 499 | 275 | −96,46 | 49,44 | −370 751 | 13 596 | |
2020-05-20 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 7 499 | 7 774 | 2 726,91 | 25,60 | 191 974 | 199 014 | |
2020-03-10 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −449 | 0 | −100,00 | ||||
2020-03-10 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −174 | 275 | −38,75 | 12,48 | −2 172 | 3 432 | |
2020-03-10 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 449 | 449 | |||||
2019-09-30 |
|
4 | NVAX |
NOVAVAX INC
Stock Option Right to Buy |
A - Award | 99 000 | 99 000 | |||||
2019-09-30 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 11 919 | 11 919 | |||||
2019-09-30 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 30 900 | 30 900 | |||||
2019-09-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −3 643 | 0 | −100,00 | 7,07 | −25 757 | ||
2019-09-10 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
M - Exercise | −4 933 | 0 | −100,00 | ||||
2019-09-10 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
F - Taxes | −1 643 | 3 643 | −31,08 | 5,50 | −9 036 | 20 036 | |
2019-09-10 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
M - Exercise | 4 933 | 5 286 | 1 397,45 | ||||
2019-03-12 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 44 979 | 44 979 | |||||
2019-03-12 |
|
4 | NVAX |
NOVAVAX INC
Restricted Stock Units |
A - Award | 98 676 | 98 676 | |||||
2018-12-14 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 400 000 | 400 000 | |||||
2017-12-19 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 400 000 | 400 000 | |||||
2017-02-02 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 4 960 | 7 072 | 234,85 | 1,12 | 5 555 | 7 921 | |
2016-11-16 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 125 000 | 125 000 | |||||
2016-11-16 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to Buy) |
A - Award | 125 000 | 125 000 | |||||
2016-03-17 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to buy) |
A - Award | 225 000 | 225 000 | |||||
2016-02-01 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 2 072 | 2 112 | 5 180,00 | 4,38 | 9 075 | 9 251 | |
2015-12-18 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
S - Sale | −27 945 | 40 | −99,86 | 8,64 | −241 420 | 346 | |
2015-08-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 1 502 | 27 985 | 5,67 | 2,28 | 3 425 | 63 806 | |
2015-03-09 |
|
4 | NVAX |
NOVAVAX INC
Stock Option (Right to buy) |
A - Award | 200 000 | 200 000 | |||||
2015-02-03 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 9 869 | 26 483 | 59,40 | 2,28 | 22 501 | 60 381 | |
2014-08-04 |
|
4 | NVAX |
NOVAVAX INC
Common Stock |
P - Purchase | 8 950 | 16 614 | 116,78 | 2,28 | 20 406 | 37 880 | |
2014-06-17 |
|
4 | NVAX |
NOVAVAX INC
Employee Stock Option (Right to buy) |
A - Award | 50 000 | 595 000 | 9,17 | ||||
2014-06-17 | 3 | NVAX |
NOVAVAX INC
Common Stock |
15 328 | ||||||||
2014-06-17 | 3 | NVAX |
NOVAVAX INC
Common Stock |
15 328 |